GGB is committed to providing updated news and analysis on our weekly news site, GGBNews.com.

Leap Forward Receives Nevada Approval

System supplier Leap Forward Gaming announced that it has received regulatory approval from the Nevada Gaming Control Board for its SaffariNet Patron Display Interface (PDI) picture-in-picture multimedia ecosystem technology for use in gaming machines and systems, after completing a successful regulatory field trial at the Atlantic Casino Resort Spa in Reno.

PDI is a scalable, low-cost, turn-key solution that works seamlessly with all brands and generations of gaming machines and systems to develop, dynamically manage and present content to players. It is a completely customizable system utilizing existing machine displays and supports all screen sizes, resolutions and aspect ratios by utilizing web-based technology. 

PDI offers targeted marketing and bonusing campaigns, progressives, drink ordering, live keno and straightforward integration with multiple player tracking and CRM systems. As part of the patented SaffariNet ecosystem, PDI agnostically provides operators with high flexibility and agile content production, and implementation utilizing web-based technologies such as HTML5, Silverlight, Flash, etc.

 

    Recent Feature Articles

  • Your Friend, Everi

    The supplier’s quest to raise all tides and all boats.

  • Gambling on the Mediterranean

    There are more gaming options in the region than expected, but things are about to change with massive projects planned for Greece and the Emirates

  • Threat or Opportunity?

    Gaming in the metaverse will look different than today’s gaming, but will it add value to the existing gaming companies, attract more players and pass regulatory scrutiny?

  • A Force in Sports Betting

    The third annual Bet Bash was designed by founder Gadoon “Spanky” Kyrollos to make gamblers better at wagering on sports

  • Problem Gambling Treatments Gain Ground

    Problem gambling wasn’t classified as a psychiatric disorder until 1980, but treatments are evolving and becoming more effective